Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
07.09.2022 - Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present and participate in the following investor ...